The smoking-Associated oxidant hypothiocyanous acid induces endothelial nitric oxide synthase dysfunction

Biochemical Journal

Volumn 457, Issue 1, 2014, Pages 89-97

  Talib, Jihan ^a,b   Kwan, Jair ^a,b   Suryo Rahmanto, Aldwin ^a,b   Davies, Michael J ^a,b   Witting, Paul K ^c  

^a HEART RESEARCH INSTITUTE   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Hypochlorous acid; Hypothiocyanous acid; Myeloperoxidase; Smoking; Thiol oxidation

Indexed keywords

CYCLIC GMP; DIMER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; HYPOTHIOCYANOUS ACID; MONOMER; MYELOPEROXIDASE; OXIDIZING AGENT; THIOL; UNCLASSIFIED DRUG; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME DEFECT; HUMAN; HUMAN CELL; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SMOKING; VASCULAR RING;

ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; HUMANS; HYPOCHLOROUS ACID; MALE; NITRIC OXIDE SYNTHASE TYPE III; OXIDANTS; PEROXIDASE; PROTEIN MULTIMERIZATION; RATS; RATS, WISTAR; SMOKING; THIOCYANATES;

EID: 84890095543     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20131135     Document Type: Article

References (51)

1. O'Donnell, C. J. and Kannel, W. B. (2003) Epidemiology of atherosclerotic vascular disease. In Panvascular Medicine (Lanzer, P. T. and Topel, E. J., eds), Springer-Verlag, Berlin
2. Yamagishi, K., Iso, H., Kitamura, A., Sankai, T., Tanigawa, T., Naito, Y., Sato, S., Imano, H., Ohira, T. and Shimamoto, T. (2003) Smoking raises the risk of total and ischemic strokes in hypertensive men. Hypertens. Res. 26, 209-217
3. Chelland Campbell, S., Moffatt, R. J. and Stamford, B. A. (2008) Smoking and smoking cessation: the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 201, 225-235
4. Libby, P., Ridker, P. M. and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation 105, 1135-1143
5. Perlstein, T. S. and Lee, R. T. (2006) Smoking, metalloproteinases, and vascular disease. Arterioscler., Thromb., Vasc. Biol. 26, 250-256
6. Jaimes, E. A., DeMaster, E. G., Tian, R. X. and Raij, L. (2004) Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler., Thromb., Vasc. Biol. 24, 1031-1036
7. Reilly, M., Delanty, N., Lawson, J. A. and FitzGerald, G. A. (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94, 19-25
8. Bermudez, E. A., Rifai, N., Buring, J. E., Manson, J. E. and Ridker, P. M. (2002) Relation between markers of systemic vascular inflammation and smoking in women. Am. J. Cardiol. 89, 1117-1119
9. Morgan, P. E., Pattison, D. I., Talib, J., Summers, F. A., Harmer, J. A., Celermajer, D. S., Hawkins, C. L. and Davies, M. J. (2011) High plasma thiocyanate levels in smokers are a key determinant of thiol oxidation induced by myeloperoxidase. Free Radical Biol. Med. 51, 1815-1822
10. Wang, Z., Nicholls, S. J., Rodriguez, E. R., Kummu, O., Horkko, S., Barnard, J., Reynolds, W. F., Topol, E. J., DiDonato, J. A. and Hazen, S. L. (2007) Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat. Med. 13, 1176-1184
11. Daugherty, A., Dunn, J. L., Rateri, D. L. and Heinecke, J. W. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94, 437-444
12. Davies, M. J., Hawkins, C. L., Pattison, D. I. and Rees, M. D. (2008) Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid. Redox Signaling 10, 1199-1234
13. van der Veen, B. S., de Winther, M. P. and Heeringa, P. (2009) Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid. Redox Signaling 11, 2899-2937
14. Nicholls, S. J. and Hazen, S. L. (2005) Myeloperoxidase and cardiovascular disease. Arterioscler., Thromb., Vasc. Biol. 25, 1102-1111
15. van Dalen, C. J., Whitehouse, M. W., Winterbourn, C. C. and Kettle, A. J. (1997) Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem. J. 327, 487-492
16. Pattison, D. I. and Davies, M. J. (2006) Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining insight into human inflammatory diseases. Curr. Med. Chem. 13, 3271-3290
17. Skaff, O., Pattison, D. I. and Davies, M. J. (2009) Hypothiocyanous acid reactivity with low-molecular-mass and protein thiols: absolute rate constants and assessment of biological relevance. Biochem. J. 422, 111-117
18. Nagy, P., Jameson, G. N. and Winterbourn, C. C. (2009) Kinetics and mechanisms of the reaction of hypothiocyanous acid with 5-thio-2-nitrobenzoic acid and reduced glutathione. Chem. Res. Toxicol. 22, 1833-1840
19. Skaff, O., Pattison, D. I., Morgan, P. E., Bachana, R., Jain, V. K., Priyadarsini, K. I. and Davies, M. J. (2012) Selenium-containing amino acids are major targets for myeloperoxidase-derived hypothiocyanous acid: determination of absolute rate constants and implications for biological damage. Biochem. J. 441, 305-316
20. Cook, N. L., Pattison, D. I. and Davies, M. J. (2012) Myeloperoxidase-derived oxidants rapidly oxidize and disrupt zinc-cysteine/histidine clusters in proteins. Free Radical Biol. Med. 53, 2072-2080
21. Buttery, L. D., Springall, D. R., Chester, A. H., Evans, T. J., Standfield, E. N., Parums, D. V., Yacoub, M. H. and Polak, J. M. (1996) Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest. 75, 77-85
22. Cromheeke, K. M., Kockx, M. M., De Meyer, G. R., Bosmans, J. M., Bult, H., Beelaerts, W. J., Vrints, C. J. and Herman, A. G. (1999) Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc. Res. 43, 744-754
23. Zou, M. H., Shi, C. and Cohen, R. A. (2002) Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 109, 817-826
24. Xu, J., Xie, Z., Reece, R., Pimental, D. and Zou, M. H. (2006) Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Arterioscler., Thromb., Vasc. Biol. 26, 2688-2695
25. Stocker, R., Huang, A., Jeranian, E., Hou, J. Y., Wu, T. T., Thomas, S. R. and Keaney, J. F. (2004) Hypochlorous acid impairs endothelium-derived nitric oxide bioactivity through a superoxide-dependent mechanism. Arterioscler., Thromb., Vasc. Biol. 24, 2028-2033
26. Furtmuller, P. G., Jantschko, W., Regelsberger, G., Jakopitsch, C., Arnhold, J. and Obinger, C. (2002) Reaction of lactoperoxidase compound I with halides and thiocyanate. Biochemistry 41, 11895-11900
27. 2 solutions in the UV). Anal. Biochem. 49, 474-478
28. Lane, A. E., Tan, J. T., Hawkins, C. L., Heather, A. K. and Davies, M. J. (2010) The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages. Biochem. J. 430, 161-169
29. Thomas, E. L. (1981) Lactoperoxidase-catalyzed oxidation of thiocyanate: equilibria between oxidized forms of thiocyanate. Biochemistry 20, 3273-3280
30. Eyer, P., Worek, F., Kiderlen, D., Sinko, G., Stuglin, A., Simeon-Rudolf, V. and Reiner, E. (2003) Molar absorption coefficients for the reduced Ellman reagent: reassessment. Anal. Biochem. 312, 224-227
31. Meeusen, J. W., Tomasiewicz, H., Nowakowski, A. and Petering, D. H. (2011) TSQ (6-methoxy-8-p-toluenesulfonamido-quinoline), a common fluorescent sensor for cellular zinc, images zinc proteins. Inorg. Chem. 50, 7563-7573
32. Lloyd, M. M., Grima, M. A., Rayner, B. S., Hadfield, K. A., Davies, M. J. and Hawkins, C. L. (2013) Comparative reactivity of the myeloperoxidase-derived oxidants hypochlorous acid (HOCl) and hypothiocyanous acid (HOSCN) with human coronary artery endothelial cells. Free Radical Biol. Med., doi:10.1016/j. freeradbiomed.2013.10.007
33. Davies, M. J. (2011) Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J. Clin. Biochem. Nutr. 48, 8-19
34. Talib, J., Pattison, D. I., Harmer, J. A., Celermajer, D. S. and Davies, M. J. (2012) High plasma thiocyanate levels modulate protein damage induced by myeloperoxidase and perturb measurement of 3-chlorotyrosine. Free Radical Biol. Med. 53, 20-29
35. Bridges, R. B., Wyatt, R. J. and Rehm, S. R. (1985) Effect of smoking on peripheral blood leukocytes and serum antiproteases. Eur. J. Resp. Dis., Suppl. 139, 24-33
36. Rudolph, T. K., Rudolph, V. and Baldus, S. (2008) Contribution of myeloperoxidase to smoking-dependent vascular inflammation. Proc. Am. Thorac. Soc. 5, 820-823
37. Hazell, L. J., Arnold, L., Flowers, D., Waeg, G., Malle, E. and Stocker, R. (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97, 1535-1544
38. Hazell, L. J., Baernthaler, G. and Stocker, R. (2001) Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis. Free Radical Biol. Med. 31, 1254-1262
39. Hazen, S. L., Gaut, J. P., Crowley, J. R., Hsu, F. F. and Heinecke, J. W. (2000) Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions. Biochem. J. 352, 693-699
40. Zheng, L., Nukuna, B., Brennan, M. L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L. et al. (2004) Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest. 114, 529-541
41. Pattison, D. I., Davies, M. J. and Hawkins, C. L. (2012) Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids. Free Radical Res. 46, 975-995
42. Xu, Y., Szep, S. and Lu, Z. (2009) The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases. Proc. Natl. Acad. Sci. U.S.A. 106, 20515-20519
43. Chandler, J. D. and Day, B. J. (2012) Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties. Biochem. Pharmacol. 84, 1381-1387
44. Bozonet, S. M., Scott-Thomas, A. P., Nagy, P. and Vissers, M. C. (2010) Hypothiocyanous acid is a potent inhibitor of apoptosis and caspase 3 activation in endothelial cells. Free Radical Biol. Med. 49, 1054-1063
45. Lloyd, M. M., van Reyk, D. M., Davies, M. J. and Hawkins, C. L. (2008) Hypothiocyanous acid is a more potent inducer of apoptosis and protein thiol depletion in murine macrophage cells than hypochlorous acid or hypobromous acid. Biochem. J. 414, 271-280
46. Morris, J. C. (1966) The acid ionization constant of HOCl from 5°C to 35°C. J. Phys. Chem. 70, 3798-3805
47. Zhang, C., Patel, R., Eiserich, J. P., Zhou, F., Kelpke, S., Ma, W., Parks, D. A., Darley-Usmar, V. and White, C. R. (2001) Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid. Am. J. Physiol. Heart Circ. Physiol. 281, H1469-H1475
48. Pattison, D. I., Hawkins, C. L. and Davies, M. J. (2007) Hypochlorous acid-mediated protein oxidation: how important are chloramine transfer reactions and protein tertiary structure? Biochemistry 46, 9853-9864
49. Peskin, A. V. and Winterbourn, C. C. (2001) Kinetics of the reactions of hypochlorous acid and amino acid chloramines with thiols, methionine, and ascorbate. Free Radical Biol. Med. 30, 572-579
50. Zhang, C., Reiter, C., Eiserich, J. P., Boersma, B., Parks, D. A., Beckman, J. S., Barnes, S., Kirk, M., Baldus, S., Darley-Usmar, V. M. and White, C. R. (2001) L-Arginine chlorination products inhibit endothelial nitric oxide production. J. Biol. Chem. 276, 27159-27165
51. -/-mice. Arterioscler., Thromb., Vasc. Biol. 28, 84-89